AAAAAA

   
Results: 1-22 |
Results: 22

Authors: Flynn, AA Pedley, RB Green, AJ Boxer, GM Boden, R Dearling, J Bhatia, J Begent, RHJ
Citation: Aa. Flynn et al., Effectiveness of radiolabelled antibodies for radio-immunotherapy in a colorectal xenograft model: a comparative study using the linear-quadratic formulation, INT J RAD B, 77(4), 2001, pp. 507-517

Authors: Flynn, AA Boxer, GM Begent, RHJ Pedley, RB
Citation: Aa. Flynn et al., Relationship between tumour morphology, antigen and antibody distribution measured by fusion of digital phosphor and photographic images, CANCER IMMU, 50(2), 2001, pp. 77-81

Authors: Flynn, AA Green, AJ Pedley, RB Boxer, GM Boden, R Begent, RHJ
Citation: Aa. Flynn et al., A mouse model for calculating the absorbed beta-particle dose from I-131- and Y-90-labeled immunoconjugates, including a method for dealing with heterogeneity in kidney and tumor, RADIAT RES, 156(1), 2001, pp. 28-35

Authors: Green, AJ Johnson, CJ Adamson, KL Begent, RHJ
Citation: Aj. Green et al., Mathematical model of antibody targeting: important parameters defined using clinical data, PHYS MED BI, 46(6), 2001, pp. 1679-1693

Authors: Cooke, SP Boxer, GM Lawrence, L Pedley, RB Spencer, DIR Begent, RHJ Chester, KA
Citation: Sp. Cooke et al., A strategy for antitumor vascular therapy by targeting the vascular endothelial growth factor : receptor complex, CANCER RES, 61(9), 2001, pp. 3653-3659

Authors: Pedley, RB Hill, SA Boxer, GM Flynn, AA Boden, R Watson, R Dearling, J Chaplin, DJ Begent, RHJ
Citation: Rb. Pedley et al., Eradication of colorectal xenografts by combined radioimmunotherapy and combretastatin A-4 3-O-phosphate, CANCER RES, 61(12), 2001, pp. 4716-4722

Authors: Webley, SD Francis, RJ Pedley, RB Sharma, SK Begent, RHJ Hartley, JA Hochhauser, D
Citation: Sd. Webley et al., Measurement of the critical DNA lesions produced by antibody-directed enzyme prodrug therapy (ADEPT) in vitro, in vivo and in clinical material, BR J CANC, 84(12), 2001, pp. 1671-1676

Authors: Mayer, A Tsiompanou, E O'Malley, D Boxer, GM Bhatia, J Flynn, AA Chester, KA Davidson, BR Lewis, AAM Winslet, MC Dhillon, AP Hilson, AJW Begent, RHJ
Citation: A. Mayer et al., Radioimmunoguided surgery in colorectal cancer using a genetically engineered anti-CEA single-chain Fv antibody, CLIN CANC R, 6(5), 2000, pp. 1711-1719

Authors: Napier, MP Sharma, SK Springer, CJ Bagshawe, KD Green, AJ Martin, J Stribbling, SM Cushen, N O'Malley, D Begent, RHJ
Citation: Mp. Napier et al., Antibody-directed enzyme prodrug therapy: Efficacy and mechanism of actionin colorectal carcinoma, CLIN CANC R, 6(3), 2000, pp. 765-772

Authors: Chester, KA Mayer, A Bhatia, J Robson, L Spencer, DIR Cooke, SP Flynn, AA Sharma, SK Boxer, G Pedley, RB Begent, RHJ
Citation: Ka. Chester et al., Recombinant anti-carcinoembryonic antigen antibodies for targeting cancer, CANC CHEMOT, 46, 2000, pp. S8-S12

Authors: Chester, KA Bhatia, J Boxer, G Cooke, SP Flynn, AA Huhalov, A Mayer, A Pedley, RB Robson, L Sharma, SK Spencer, DIR Begent, RHJ
Citation: Ka. Chester et al., Clinical applications of phage-derived sFvs and sFv fusion proteins, DIS MARKER, 16(1-2), 2000, pp. 53-62

Authors: Boehm, MK Corper, AL Wan, T Sohi, MK Sutton, BJ Thornton, JD Keep, PA Chester, KA Begent, RHJ Perkins, SJ
Citation: Mk. Boehm et al., Crystal structure of the anti-(carcinoembryonic antigen) single-chain Fv antibody MFE-23 and a model for antigen binding based on intermolecular contacts, BIOCHEM J, 346, 2000, pp. 519-528

Authors: Verhaar-Langereis, MJ Eagle, KF Keep, PA Casey, JL Begent, RHJ
Citation: Mj. Verhaar-langereis et al., Anaphylactic reaction to radioimmunotherapy despite plasmapheresis to remove anti-mouse antibodies, J ROY S MED, 93(2), 2000, pp. 75-76

Authors: Bhatia, J Sharma, SK Chester, KA Pedley, RB Boden, RW Read, DA Boxer, GM Michael, NP Begent, RHJ
Citation: J. Bhatia et al., Catalytic activity of an in vivo tumor targeted anti-CEA scFv :: carboxypeptidase G2 fusion protein, INT J CANC, 85(4), 2000, pp. 571-577

Authors: Casey, JL Pedley, RB King, DJ Boden, R Chapman, AP Yarranton, GT Begent, RHJ
Citation: Jl. Casey et al., Improved tumour targeting of di-Fab ' fragments modified with polyethyleneglycol, TUMOR TARG, 4(4), 1999, pp. 235-244

Authors: Flynn, AA Green, AJ Boxer, GM Casey, JL Pedley, RB Begent, RHJ
Citation: Aa. Flynn et al., A novel technique, using radioluminography, for the measurement of uniformity of radiolabelled antibody distribution in a colorectal cancer xenograftmodel, INT J RAD O, 43(1), 1999, pp. 183-189

Authors: Flynn, AA Green, AJ Boxer, G Pedley, RB Begent, RHJ
Citation: Aa. Flynn et al., A comparison of image registration techniques for the correlation of radiolabelled antibody distribution with tumour morphology, PHYS MED BI, 44(7), 1999, pp. N151-N159

Authors: Mayer, A Chester, KA Flynn, AA Begent, RHJ
Citation: A. Mayer et al., Taking engineered anti-CEA antibodies to the clinic, J IMMUNOL M, 231(1-2), 1999, pp. 261-273

Authors: Pedley, RB Sharma, SK Boxer, GM Boden, R Stribbling, SM Davies, L Springer, CJ Begent, RHJ
Citation: Rb. Pedley et al., Enhancement of antibody-directed enzyme prodrug therapy in colorectal xenografts by an antivascular agent, CANCER RES, 59(16), 1999, pp. 3998-4003

Authors: Casey, JL Pedley, RB King, DJ Green, AJ Yarranton, GT Begent, RHJ
Citation: Jl. Casey et al., Dosimetric evaluation and radioimmunotherapy of anti-tumour multivalent Fab' fragments, BR J CANC, 81(6), 1999, pp. 972-980

Authors: Begent, RHJ
Citation: Rhj. Begent, Targeting cancer therapy, BR J CANC, 80, 1999, pp. 104-109

Authors: Al-Mufti, RAM Pedley, RB Marshall, D Begent, RHJ Hilson, A Winslet, MC Hobbs, KEF
Citation: Ram. Al-mufti et al., In vitro assessment of Lipiodol-targeted radiotherapy for liver and colorectal cancer cell lines, BR J CANC, 79(11-12), 1999, pp. 1665-1671
Risultati: 1-22 |